Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients.
Pauline P ChenAlma-Martina CepikaRajni Agarwal-HashmiGopin SainiMolly J UyedaDavid M LouisBrandon CieniewiczMansi NarulaLaura C Amaya HernandezNicholas HarreLiwen XuBenjamin Craig ThomasXuhuai JiParveen ShirazKeri M TateDana MargittaiNeehar BhatiaEverett MeyerAlice BertainaMark M DavisRosa BacchettaMaria Grazia RoncaroloPublished in: Science translational medicine (2021)
[Figure: see text].